Target intelligence / Profile preview

Elongin C pseudogene 16 (ELOCP16)

Target
ELOCP16
Molecular classification
Other (pseudogene)
01

Overview

Elongin C pseudogene 16 (ELOCP16) is a human pseudogene related to the functional ELOC (elongin C) gene, which in its active form encodes a regulatory subunit of the transcription factor B (SIII) complex involved in RNA polymerase II transcription elongation[1][3]. However, ELOCP16 itself is classified as a pseudogene, meaning it does not encode an active protein product and does not play a known role in normal cellular or disease biology. There are no known drugs, disease associations, or therapeutic relevance for this gene[2][4][5][8]. Summary of findings: ELOCP16 is not a therapeutic target. There is no evidence that it encodes a functional protein. Its relationship is to the ELOC (Elongin C) gene, which is a genuine protein-coding gene, but ELOCP16 does not share the same functional significance. The pseudogene status means it is not involved in drug targeting, disease association, or molecular mechanisms relevant to therapeutic intervention[2][5][8].

Other names
TCEB1P16transcription elongation factor B (SIII) polypeptide 1 pseudogene 16transcription elongation factor B subunit 1 pseudogene 16
02

Mechanism of action

None (not targeted by drugs)

03

Biological functions

None
04

Disease associations

None
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on Elongin C pseudogene 16 (ELOCP16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 16 (ELOCP16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call